In closing, the advances that are being made in our understanding of the structure and multifaceted functions of macromolecular SLX4-complexes will no doubt feed into strategies for the molecular characterization of cancers and cancer-predisposing syndromes, the development of diagnostic, prognostic or predictive biomarkers, and the design of more efficacious cancer treatments. This evidence concerns the gene SLX4 and cancer.